Loading...
Development and Characterization of a Hydroxyl-Sulfonamide Analogue, 5-Chloro-N-[2-(4-hydroxysulfamoyl-phenyl)-ethyl]-2-methoxy-benzamide, as a Novel NLRP3 Inflammasome Inhibitor for Potential Treatment of Multiple Sclerosis
In our efforts to develop novel small-molecule inhibitors for the NOD-like receptor family pyrin-domain-containing 3 (NLRP3) inflammasome as potential disease-modifying agents to treat neurological disorders including multiple sclerosis (MS), a hydroxyl sulfonamide analogue JC-171 has been rationall...
Na minha lista:
| Udgivet i: | ACS Chem Neurosci |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5672903/ https://ncbi.nlm.nih.gov/pubmed/28653829 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acschemneuro.7b00124 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|